| Followers | 843 |
| Posts | 122977 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Wednesday, July 18, 2012 9:17:00 AM
In emerging markets, ABT logged 14% YoY constant-currency sales growth in 2Q12:
http://finance.yahoo.com/news/abbott-reports-strong-second-quarter-114400940.html
This includes sales from the entire company, i.e. both the Established Products unit and the Pharma unit that will become AbbVie.
http://finance.yahoo.com/news/abbott-reports-strong-second-quarter-114400940.html
This includes sales from the entire company, i.e. both the Established Products unit and the Pharma unit that will become AbbVie.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ABT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/29/2026 09:09:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/29/2026 08:42:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/29/2026 12:07:28 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 11:58:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 11:45:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 11:37:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 11:21:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 11:14:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 11:02:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 10:27:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 10:17:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 10:01:45 PM
- Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform • PR Newswire (US) • 04/28/2026 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/27/2026 10:34:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/27/2026 08:06:40 PM
- Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026 • PR Newswire (US) • 04/25/2026 04:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 04/24/2026 08:06:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 08:04:06 PM
- New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test • PR Newswire (US) • 04/17/2026 07:30:00 PM
- Abbott Shares Slip on Weaker Q2 Outlook Despite In-Line Q1 Results • IH Market News • 04/16/2026 02:13:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2026 11:36:25 AM
- Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences • PR Newswire (US) • 04/16/2026 11:30:00 AM
- New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health • PR Newswire (US) • 04/09/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:31:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:24:18 PM
